Technologies Available to License

At St George's Centre for Enterprise & Innovation we have extensive experience in making technology, developed through internationally renowned research, available for commercialisation.
The innovative research and development undertaken in basic and medical sciences within St George's offers great potential to interested parties for further development and commercialisation.
Please explore the case studies and opportunities below. For further information please contact a member of the team.
HOX-PBX anti-cancer peptides - a case study
Licensing Opportunities
The Use of Stromic Lymphopoetin as a vaccine adjuvant
DNA - based methods for clone specific indentification of Staphlocococcus aureus
Production of compounds by rhizosecretion from plants
